Glenmark cleared to market Evista generic
MUMBAI, India — Glenmark Pharmaceuticals Inc. USA has received final approval from the Food & Drug Administration for raloxifene hydrochloride tablet. Glenmark said Wednesday that its raloxifene product is a generic equivalent of Evista tablets (60 mg) from Eli Lilly and Co. Raloxifene, which reduces the loss of bone tissue, is indicated for the treatment
